Filing Details
- Accession Number:
- 0001225208-15-002879
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-03 17:19:39
- Reporting Period:
- 2015-01-30
- Filing Date:
- 2015-02-03
- Accepted Time:
- 2015-02-03 17:19:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 912513 | Cytec Industries Inc | CYT | Miscellaneous Chemical Products (2890) | 223268660 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1574904 | Michael J Radossich | Five Garret Mountain Plaza Woodland Park NJ 07424 | President, Specialty Chemicals | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-01-30 | 1,382 | $0.00 | 2,502 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-03 | 523 | $50.01 | 1,979 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit 2012 | Disposition | 2015-01-30 | 1,382 | $0.00 | 1,382 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 7,180 | Indirect | Savings Plan |
Footnotes
- The restricted stock units granted on January 30, 2012 were converted into an equal number of common stock for no additional consideration.
- The sales price ranged from $50.0101 to $50.08 with a weighted average of $50.0102. The undersigned reporting person hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Excludes shares held in Employees' Savings Plan or Supplemental Plan which are eligible for deferred reporting on Form 5, as per note to instruction 4(a)(i).
- 100% of the restricted stock units award vested and converted into common stock on the 3rd anniversary of the grant date.
Billionaire Hedge Funds
